126 related articles for article (PubMed ID: 29885760)
1. TRP63/TP63 loss accelerates skin tumorigenesis through activation of Wnt/β-catenin signaling.
Lakshmanachetty S; Balaiya V; Johnson LK; Koster MI
J Dermatol Sci; 2018 Sep; 91(3):325-328. PubMed ID: 29885760
[No Abstract] [Full Text] [Related]
2. Multicolour lineage tracing reveals clonal dynamics of squamous carcinoma evolution from initiation to metastasis.
Reeves MQ; Kandyba E; Harris S; Del Rosario R; Balmain A
Nat Cell Biol; 2018 Jun; 20(6):699-709. PubMed ID: 29802408
[TBL] [Abstract][Full Text] [Related]
3. Differential gene expression during tumor promotion and progression in the mouse skin model.
Bowden GT; Ostrowski LE; Bonham K; Krieg P
Basic Life Sci; 1991; 57():127-40; discussion 140-1. PubMed ID: 1667569
[No Abstract] [Full Text] [Related]
4. Lgr4 is crucial for skin carcinogenesis by regulating MEK/ERK and Wnt/β-catenin signaling pathways.
Xu P; Dang Y; Wang L; Liu X; Ren X; Gu J; Liu M; Dai X; Ye X
Cancer Lett; 2016 Dec; 383(2):161-170. PubMed ID: 27693558
[TBL] [Abstract][Full Text] [Related]
5. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
[TBL] [Abstract][Full Text] [Related]
6. Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility.
Cipolat S; Hoste E; Natsuga K; Quist SR; Watt FM
Elife; 2014 May; 3():e01888. PubMed ID: 24843010
[TBL] [Abstract][Full Text] [Related]
7. Suppression of skin tumorigenesis in CD109-deficient mice.
Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
[TBL] [Abstract][Full Text] [Related]
8. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.
Dai C; Whitesell L; Rogers AB; Lindquist S
Cell; 2007 Sep; 130(6):1005-18. PubMed ID: 17889646
[TBL] [Abstract][Full Text] [Related]
9. Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.
Bajpai D; Mehdizadeh S; Uchiyama A; Inoue Y; Sawaya A; Overmiller A; Brooks SR; Hasneen K; Kellett M; Palazzo E; Motegi SI; Yuspa SH; Cataisson C; Morasso MI
Oncogene; 2021 May; 40(21):3680-3694. PubMed ID: 33947961
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression.
Koster MI; Lu SL; White LD; Wang XJ; Roop DR
Cancer Res; 2006 Apr; 66(8):3981-6. PubMed ID: 16618715
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis.
Li J; Zheng H; Yu F; Yu T; Liu C; Huang S; Wang TC; Ai W
Carcinogenesis; 2012 Jun; 33(6):1239-46. PubMed ID: 22491752
[TBL] [Abstract][Full Text] [Related]
12. Functional roles of Akt signaling in mouse skin tumorigenesis.
Segrelles C; Ruiz S; Perez P; Murga C; Santos M; Budunova IV; Martínez J; Larcher F; Slaga TJ; Gutkind JS; Jorcano JL; Paramio JM
Oncogene; 2002 Jan; 21(1):53-64. PubMed ID: 11791176
[TBL] [Abstract][Full Text] [Related]
13. Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis.
Darido C; Georgy SR; Wilanowski T; Dworkin S; Auden A; Zhao Q; Rank G; Srivastava S; Finlay MJ; Papenfuss AT; Pandolfi PP; Pearson RB; Jane SM
Cancer Cell; 2011 Nov; 20(5):635-48. PubMed ID: 22094257
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.
Moses MA; George AL; Sakakibara N; Mahmood K; Ponnamperuma RM; King KE; Weinberg WC
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340447
[TBL] [Abstract][Full Text] [Related]
15. E1a is an exogenous in vivo tumour suppressor.
Cimas FJ; Callejas-Valera JL; García-Olmo DC; Hernández-Losa J; Melgar-Rojas P; Ruiz-Hidalgo MJ; Pascual-Serra R; Ortega-Muelas M; Roche O; Marcos P; Garcia-Gil E; Fernandez-Aroca DM; Ramón Y Cajal S; Gutkind JS; Sanchez-Prieto R
Cancer Lett; 2017 Jul; 399():74-81. PubMed ID: 28416454
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion.
Darwiche N; Ryscavage A; Perez-Lorenzo R; Wright L; Bae DS; Hennings H; Yuspa SH; Glick AB
Oncogene; 2007 Oct; 26(48):6885-95. PubMed ID: 17525749
[TBL] [Abstract][Full Text] [Related]
18. PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis.
Chen L; Hayden MS; Gilmore ES; Alexander-Savino C; Oleksyn D; Gillespie K; Zhao J; Poligone B
Carcinogenesis; 2018 Mar; 39(3):418-428. PubMed ID: 29186361
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis.
Brennan-Crispi DM; Hossain C; Sahu J; Brady M; Riobo NA; Mahoney MG
Oncotarget; 2015 Apr; 6(11):8593-605. PubMed ID: 25871385
[TBL] [Abstract][Full Text] [Related]
20. C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event.
Messenger ZJ; Hall JR; Jima DD; House JS; Tam HW; Tokarz DA; Smart RC
Cell Death Dis; 2018 Oct; 9(11):1054. PubMed ID: 30323292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
